MedTrace Logo

Adherence Monitoring For Substance Abuse Clinical Trials

NCT01867476 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2013-06-04

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility and accuracy of an automated adherence monitoring system, and to compare the variance between urine and oral fluid riboflavin levels when specimens are obtained 'as usual' and after a one-hour inter specimen interval.

Conditions

  • Medication Adherence

Interventions

OTHER

Automated Adherence Monitoring System

Sponsors & Collaborators

  • Creare, Inc.

    collaborator INDUSTRY

  • California Pacific Medical Center Research Institute

    lead OTHER

Principal Investigators

  • John Mendelson, MD · California Pacific Medical Center

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01867476 on ClinicalTrials.gov